Horizon Therapeutics PLC (HZNP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

CONNAUGHT HOUSE, 1ST FLOOR DUBLIN, IRELAND 4

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The Company pipeline is purposeful: it applyie scientific expertise and courages to bring clinically meaningful therapies to patients. The Company believes science and compassion must work together to transform lives.

Data as of 2021-04-11 07:18:45 -0400
Market Cap20.498 Billion Shares Outstanding224.074 Million Avg 30-day Volume2 Million
P/E Ratio52.58732 Dividend Yield EPS1.81
Price/Sales9.32 Debt to Equity1.51 EBITDA764.594 Million
Price to Book Value5.09 Forward PE25.29 Enterprise Value19.422 Billion
Total Cash2.08 Billion Current Debt875.74 Million Gross Profit1.668 Billion
BETA0.90359 52-week High/Low96.54 / 30.0 Next Earnings Date2021-05-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from HZNP instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 23 33 -30.3% 16 (0.96%) 23 (1.43%) -30.43%
Funds Holding: 477 426 11.97% 141 (8.47%) 145 (9.03%) -2.76%
13F shares: 198.937 Million 195.524 Million 1.75% 80.143 Million 80.856 Million -0.88%
% Ownership 90.1349 88.5887 1.75% 36.3113 36.6344 -0.88%
New Positions: 119 116 2.59% 29 43 -32.56%
Increased Positions 169 150 12.67% 44 45 -2.22%
Closed Positions 61 38 60.53% 31 15 106.67%
Reduced Positions 158 139 13.67% 62 50 24.0%
Total Calls 4.181 Million 1.269 Million 229.46% 2.198 Million 687.641 Thousand 219.66%
Total Puts 1.677 Million 1.687 Million -0.6% 674.177 Thousand 471.5 Thousand 42.99%
PUT/CALL Ratio 0.4 1.33 -69.92% 0.31 0.69 -55.07%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding HZNP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HZNP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

268.4 Thousand total shares from 21 transactions

Exercise Derivative Conversion (M)

81 Thousand total shares from 9 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GREY MICHAEL G

  • Director
67,290 2021-04-12 6

MOZE BARRY EVP, CHIEF ADMIN. OFFICER

  • Officer
105,665 2021-04-12 7

CAMARDO DANIEL A. EVP AND PRESIDENT, U.S.

  • Officer
58,955 2021-04-05 9

CURTIS GEOFFREY M. EVP, CORPORATE AFFAIRS, CCO

  • Officer
53,095 2021-04-01 5

BEELER BRIAN K EVP, GENERAL COUNSEL

  • Officer
95,677 2021-03-31 8

WALBERT TIMOTHY P CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
944,783 2021-03-01 7

SANTINI GINO

  • Director
63,303 2021-03-01 3

SHANNON JAMES SAMUEL

  • Director
53,604 2021-03-01 3

DESJARDIN MICHAEL A. EVP, TECHNICAL OPERATIONS

  • Officer
86,247 2021-02-24 11

KARNANI VIKRAM EVP & PRESIDENT, INTERNATIONAL

  • Officer
104,165 2021-02-22 8

KONSTANTINOVSKY IRINA EVP, CHIEF HUMAN RESOURCES OFF

  • Officer
81,677 2021-02-22 8

SHERMAN JEFFREY W EVP AND CHIEF MEDICAL OFFICER

  • Officer
263,717 2021-02-17 7

HOELSCHER PAUL W. EVP, CFO

  • Officer
278,562 2021-02-17 5

KENT JEFF SEE REMARKS

  • Officer
70,994 2021-02-17 7

PASTERNAK ANDY EVP AND CHIEF BUSINESS OFFICER

  • Officer
17,742 2021-02-17 3

MCHUGH MILES W SR VP & PRINC. ACCTG OFFICER

  • Officer
33,615 2021-01-21 7

ROSEN KARIN EVP, R&D & CSO

  • Officer
0 2021-01-04 3

WITZ PASCALE

  • Director
34,611 2020-08-02 2

HIMAWAN JEFF

  • Director
42,881 2020-04-30 1

WATKINS THOMAS

  • Director
75,843 2020-04-30 1

DANIEL WILLIAM F

  • Director
66,362 2020-04-30 1

MAHONY SUSAN

  • Director
7,311 2020-04-30 1

LIN SHAO-LEE EVP, HEAD OF R&D AND CSO

  • Officer
109,668 2020-01-21 0

PAULI RONALD

  • Director
33,600 2019-05-02 0

CAREY ROBERT EVP, CHIEF BUSINESS OFFICER

  • Officer
266,358 2019-03-23 0

WALBERT TIMOTHY P CHAIRMAN, PRESIDENT AND CEO

WALBERT TIMOTHY P CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
680,757 2019-01-04 7

HAMPTON GEORGE P EVP, PRIMARY CARE BUS. UNIT

  • Officer
41,473 2018-04-01 0

MOSBROOKER ERIC SVP, ORPHAN BUSINESS UNIT

  • Officer
3,585 2017-11-01 0

HAPPEL DAVID EVP, COMMERCIAL DEV & STRATEGY

  • Officer
5,089 2017-10-25 0

NOHRIA VIRINDER

  • Director
No longer subject to file 2017-05-03 0

ACKERMAN TIMOTHY J. SVP, COMMERCIAL OPERATIONS

  • Officer
41,129 2017-01-10 0

THOMAS JOHN B EVP, CORPORATE STRATEGY AND IR

  • Officer
7,620 2016-05-06 0

KELLY DAVID GEORGE EVP, COMPANY SECRETARY

  • Officer
145,138 2016-03-23 0

KODY JOHN J EVP, CHIEF COMMERCIAL OFFICER

  • Officer
12,766 2015-11-24 0

VENKATARAMAN BALAJI

  • FORMER 10% OWNER
No longer subject to file 2014-11-13 0

DE VAERE ROBERT J EVP & CFO

  • Officer
No longer subject to file 2014-09-30 0

VIDARA THERAPEUTICS HOLDINGS LLC

  • 10% Owner
  • FORMER 10% OWNER
No longer subject to file 2014-09-22 0

SMITH TODD N EVP, CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2014-09-19 0

BIRD JEFFREY W

  • Director
3,028,304 2013-12-13 0

ADATTO MICHAEL SVP, MANAGED CARE & COMM. DEV.

  • Officer
22,911 2012-12-31 0

QUAKER BIOVENTURES II LP

  • 10% Owner
3,516,009 2012-10-09 0

FORMELA JEAN FRANCOIS

  • Director
  • 10% Owner
No longer subject to file 2012-03-02 0

ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

  • 10% Owner
5,064,731 2012-03-02 0

ATLAS VENTURE FUND VI LP

ATLAS VENTURE FUND VI GMBH & CO KG

ATLAS VENTURE ASSOCIATES VI, L.P.

ATLAS VENTURE ENTREPRENEURS FUND VI LP

  • 10% Owner
No longer subject to file 2012-03-02 0

ATLAS VENTURE FUND VI LP

ATLAS VENTURE ASSOCIATES VI, INC

ATLAS VENTURE ENTREPRENEURS FUND VI LP

ATLAS VENTURE FUND VI GMBH & CO KG

  • 10% Owner
5,393,178 2011-08-02 0

SCALE VENTURE PARTNERS II, LP

SCALE VENTURE MANAGEMENT II, LLC

MITCHELL KATE

O'DRISCOLL RORY

WIENBAR SHARON L

  • 10% Owner
2,204,465 2011-08-02 0

BOCK LOUIS C

  • Director
2,204,465 2011-08-02 0

JOHANN PETER

  • Director
4,590,751 2011-08-02 0

BIRNER HUBERT

  • Director
1,981,049 2011-08-02 0

NGN BIOMED OPPORTUNITY I GMBH & CO. BETEILIGUNGS KG

NGN BIOMED OPPORTUNITY I L P

  • 10% Owner
123,287 2011-07-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2021-04-13 18:04:21 -0400 2021-04-12 S 6,165 $90.30 d 105,665 direct yes 2.2526 2.2526 2 0.0 1

GREY MICHAEL G - Director

2021-04-13 18:03:14 -0400 2021-04-12 M 15,000 d 5,000 direct

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2021-04-13 18:04:21 -0400 2021-04-12 S 8,195 $89.60 d 111,830 direct yes 2.2526 2.2526 2 0.0 1

GREY MICHAEL G - Director

2021-04-13 18:03:14 -0400 2021-04-12 S 15,000 $90.28 d 0 direct yes 2.2526 2.2526 2 0.0 1

MOZE BARRY - Officer EVP, CHIEF ADMIN. OFFICER

2021-04-13 18:04:21 -0400 2021-04-12 S 51,253 $88.70 d 120,025 direct yes 2.2526 2.2526 2 0.0 1

GREY MICHAEL G - Director

2021-04-13 18:03:14 -0400 2021-04-12 M 15,000 $2.37 a 15,000 direct 2.2526 2.2526 2 0.0 1

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-04-05 17:25:18 -0400 2021-04-05 M 2,305 d 0 direct

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-04-05 17:25:18 -0400 2021-04-05 M 2,305 $17.19 a 35,205 direct -1.4446 1.8113 1.8113 6 -1.4446 2

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-04-05 17:25:18 -0400 2021-04-05 M 509 d 3,441 direct

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-04-05 17:25:18 -0400 2021-04-05 M 509 $15.23 a 51,181 direct -1.4446 1.8113 1.8113 6 -1.4446 2

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-04-05 17:25:18 -0400 2021-04-05 M 15,467 d 4,333 direct

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-04-05 17:25:18 -0400 2021-04-05 M 15,467 $25.52 a 50,672 direct -1.4446 1.8113 1.8113 6 -1.4446 2

CURTIS GEOFFREY M. - Officer EVP, CORPORATE AFFAIRS, CCO

2021-04-02 17:13:34 -0400 2021-04-01 S 70,739 $93.51 d 52,675 direct yes -0.9139 -1.1341 0.7267 5 -2.3453 3

CURTIS GEOFFREY M. - Officer EVP, CORPORATE AFFAIRS, CCO

2021-04-02 17:13:34 -0400 2021-04-01 M 20,000 d 0 direct

CURTIS GEOFFREY M. - Officer EVP, CORPORATE AFFAIRS, CCO

2021-04-02 17:13:34 -0400 2021-04-01 M 20,000 $29.22 a 123,414 direct -0.9139 -1.1341 0.7267 5 -2.3453 3

CURTIS GEOFFREY M. - Officer EVP, CORPORATE AFFAIRS, CCO

2021-04-02 17:13:34 -0400 2021-04-01 M 17,000 d 0 direct

CURTIS GEOFFREY M. - Officer EVP, CORPORATE AFFAIRS, CCO

2021-04-02 17:13:34 -0400 2021-04-01 M 17,000 $27.43 a 103,414 direct -0.9139 -1.1341 0.7267 5 -2.3453 3

BEELER BRIAN K - Officer EVP, GENERAL COUNSEL

2021-04-02 17:11:21 -0400 2021-03-31 S 26,844 $90.12 d 95,677 direct yes -0.9139 -1.1341 0.7267 5 -2.3453 3

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-03-31 17:11:31 -0400 2021-03-30 S 4,594 $84.97 d 39,403 direct yes 0.3536 1.0829 1.0829 6 -2.0 4

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-03-31 17:11:31 -0400 2021-03-30 S 3,517 $86.87 d 32,900 direct yes 0.3536 1.0829 1.0829 6 -2.0 4

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-03-31 17:11:31 -0400 2021-03-30 S 1,803 $83.58 d 43,997 direct yes 0.3536 1.0829 1.0829 6 -2.0 4

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-03-31 17:11:31 -0400 2021-03-30 S 2,986 $85.88 d 36,417 direct yes 0.3536 1.0829 1.0829 6 -2.0 4

WALBERT TIMOTHY P - Director - Officer CHAIRMAN, PRESIDENT AND CEO

2021-03-03 16:44:53 -0500 2021-03-01 S 24,663 $91.29 d 927,150 direct yes 2.8542 4.873 8.2144 8.4929 30 -6.973 18

SHANNON JAMES SAMUEL - Director

2021-03-03 16:46:15 -0500 2021-03-01 S 7,232 $91.30 d 0 direct 2.8542 4.873 8.2144 8.4929 30 -6.973 18

SANTINI GINO - Director

2021-03-03 16:45:28 -0500 2021-03-01 S 12,000 $91.47 d 23,795 direct 2.8542 4.873 8.2144 8.4929 30 -6.973 18

SHANNON JAMES SAMUEL - Director

2021-03-03 16:46:15 -0500 2021-03-01 M 7,232 $12.19 a 7,232 direct 2.8542 4.873 8.2144 8.4929 30 -6.973 18

WALBERT TIMOTHY P - Director - Officer CHAIRMAN, PRESIDENT AND CEO

2021-03-03 16:44:53 -0500 2021-03-01 S 2,312 $91.98 d 924,838 direct yes 2.8542 4.873 8.2144 8.4929 30 -6.973 18

SHANNON JAMES SAMUEL - Director

2021-03-03 16:46:15 -0500 2021-03-01 M 7,232 d 20,000 direct

DESJARDIN MICHAEL A. - Officer EVP, TECHNICAL OPERATIONS

2021-02-26 18:12:16 -0500 2021-02-26 S 1,099 $91.83 d 86,247 direct yes 2.8071 -5.5924 -0.3155 2.8071 2 -12.7625 21

DESJARDIN MICHAEL A. - Officer EVP, TECHNICAL OPERATIONS

2021-02-26 18:12:16 -0500 2021-02-24 S 5,158 $87.20 d 87,346 direct yes 2.8071 -5.5924 -0.3155 2.8071 2 -12.7625 21

DESJARDIN MICHAEL A. - Officer EVP, TECHNICAL OPERATIONS

2021-02-26 18:12:16 -0500 2021-02-24 S 10,786 $95.00 d 92,504 direct yes 2.8071 -5.5924 -0.3155 2.8071 2 -12.7625 21

KARNANI VIKRAM - Officer EVP & PRESIDENT, INTERNATIONAL

2021-02-23 18:20:36 -0500 2021-02-22 S 7,713 $87.08 d 104,810 direct yes -5.1424 -4.6816 -4.6921 0.0 1 -16.0243 24

KONSTANTINOVSKY IRINA - Officer EVP, CHIEF HUMAN RESOURCES OFF

2021-02-23 18:19:57 -0500 2021-02-22 S 474 $88.50 d 81,677 direct yes -5.1424 -4.6816 -4.6921 0.0 1 -16.0243 24

KARNANI VIKRAM - Officer EVP & PRESIDENT, INTERNATIONAL

2021-02-23 18:20:36 -0500 2021-02-22 S 645 $88.45 d 104,165 direct yes -5.1424 -4.6816 -4.6921 0.0 1 -16.0243 24

KONSTANTINOVSKY IRINA - Officer EVP, CHIEF HUMAN RESOURCES OFF

2021-02-23 18:19:57 -0500 2021-02-22 S 5,224 $87.11 d 82,151 direct yes -5.1424 -4.6816 -4.6921 0.0 1 -16.0243 24

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-02-23 18:18:24 -0500 2021-02-21 M 1,300 a 46,376 direct -5.1424 -4.6816 -4.6921 0.0 1 -16.0243 24

DESJARDIN MICHAEL A. - Officer EVP, TECHNICAL OPERATIONS

2021-02-23 18:19:20 -0500 2021-02-21 M 2,182 a 104,372 direct -5.1424 -4.6816 -4.6921 0.0 1 -16.0243 24

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-02-23 18:18:24 -0500 2021-02-21 M 1,300 d 0 direct

DESJARDIN MICHAEL A. - Officer EVP, TECHNICAL OPERATIONS

2021-02-23 18:19:20 -0500 2021-02-21 M 2,182 d 0 direct

CAMARDO DANIEL A. - Officer EVP AND PRESIDENT, U.S.

2021-02-23 18:18:24 -0500 2021-02-21 F 576 $88.87 d 45,800 direct -5.1424 -4.6816 -4.6921 0.0 1 -16.0243 24

DESJARDIN MICHAEL A. - Officer EVP, TECHNICAL OPERATIONS

2021-02-23 18:19:20 -0500 2021-02-21 F 1,082 $88.87 d 103,290 direct -5.1424 -4.6816 -4.6921 0.0 1 -16.0243 24

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 22:15:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 21:45:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 21:15:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 20:45:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 20:15:05 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 19:45:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 19:15:02 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 18:45:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 18:15:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 17:45:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 17:15:13 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 16:45:02 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 16:15:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 15:45:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 15:15:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 14:45:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 14:15:03 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 13:45:02 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 13:15:02 UTC -0.19 0.25 4600000
HORIZON THERAPEUTICS PLC HZNP 2021-04-19 12:45:03 UTC -0.19 0.25 4600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Jackson Variable Series Trust- JNL/Nicholas Convertible Arbitrage Fund HZNP -19350.0 shares, $-573147.0 2020-03-31 N-PORT
Nuveen Investment Trust- Nuveen Equity Market Neutral Fund HZNP -16000.0 shares, $-1126880.0 2020-11-30 N-PORT
FundVantage Trust- Gotham Defensive Long Fund HZNP -94.0 shares, $-2784.28 2020-03-31 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND HZNP -2250.0 shares, $-163080.0 2021-01-31 N-PORT

Elevate your investments